| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 6 | 0 | 0 | 6 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
| Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
| Chain A, Beta-lactamase | 4 | 0 | 0 | 4 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| thioredoxin reductase | 12 | 0 | 0 | 12 |
| GALC protein | 1 | 0 | 0 | 1 |
| GLI family zinc finger 3 | 10 | 0 | 0 | 10 |
| nuclear receptor subfamily 1, group I, member 3 | 14 | 0 | 0 | 14 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 12 | 0 | 0 | 12 |
| glucocorticoid receptor [Homo sapiens] | 15 | 0 | 0 | 15 |
| retinoic acid nuclear receptor alpha variant 1 | 11 | 0 | 0 | 11 |
| retinoid X nuclear receptor alpha | 8 | 0 | 0 | 8 |
| estrogen-related nuclear receptor alpha | 13 | 0 | 0 | 13 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| arylsulfatase A | 6 | 0 | 0 | 6 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| euchromatic histone-lysine N-methyltransferase 2 | 15 | 0 | 0 | 15 |
| Bloom syndrome protein isoform 1 | 8 | 0 | 0 | 8 |
| thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 9 | 0 | 0 | 9 |
| geminin | 14 | 0 | 0 | 14 |
| peripheral myelin protein 22 | 9 | 0 | 0 | 9 |
| survival motor neuron protein isoform d | 5 | 0 | 0 | 5 |
| muscleblind-like protein 1 isoform 1 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit pi | 5 | 2 | 0 | 7 |
| ATP-binding cassette sub-family C member 3 | 0 | 15 | 0 | 15 |
| Multidrug resistance-associated protein 4 | 0 | 15 | 0 | 16 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 12 | 0 | 2 | 1 | 6 |
| Prolyl endopeptidase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 2 |
| Bile salt export pump | 0 | 18 | 0 | 18 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Renin | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 1 | 0 | 4 | 1 | 11 |
| Carbonic anhydrase 2 | 0 | 4 | 2 | 11 |
| Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 2 | 1 | 6 |
| Cathepsin B | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 5 | 0 | 8 |
| Steryl-sulfatase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 9 | 0 | 10 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 3 | 0 | 3 |
| Cytochrome P450 2D6 | 0 | 2 | 0 | 3 |
| Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C9 | 0 | 10 | 0 | 11 |
| 5-hydroxytryptamine receptor 2A | 0 | 10 | 0 | 10 |
| Androgen receptor | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 5 | 2 | 0 | 7 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 5 | 2 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 5 | 2 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 5 | 2 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 5 | 2 | 0 | 7 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 5 | 1 | 6 |
| Carbonic anhydrase 4 | 0 | 2 | 1 | 5 |
| Carbonic anhydrase 6 | 0 | 2 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 5 | 2 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 5 | 2 | 0 | 7 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 4 | 0 | 5 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 5 | 2 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 5 | 2 | 0 | 7 |
| Endochitinase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 5 | 2 | 0 | 7 |
| Adenosine receptor A2a | 0 | 3 | 0 | 4 |
| 5-hydroxytryptamine receptor 2B | 0 | 7 | 1 | 8 |
| Sodium-dependent serotonin transporter | 0 | 5 | 0 | 5 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C19 | 0 | 6 | 0 | 7 |
| Delta-type opioid receptor | 0 | 3 | 0 | 3 |
| Mu-type opioid receptor | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 1 | 6 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 7 | 0 | 2 | 1 | 5 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 1 | 2 | 0 | 3 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| D(2) dopamine receptor | 0 | 9 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 5 | 3 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 5 | 2 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 5 | 2 | 0 | 7 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 3 | 0 | 3 |
| Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 4 | 1 | 6 |
| Squalene synthase | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 2 | 1 | 6 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Sigma intracellular receptor 2 | 0 | 2 | 0 | 2 |
| Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Renin | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Endochitinase A1 | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 2 | 1 | 4 |
| GABA theta subunit | 5 | 2 | 0 | 7 |
| Canalicular multispecific organic anion transporter 1 | 0 | 14 | 0 | 14 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 3 |
| Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 2 | 0 | 4 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 5 | 2 | 0 | 7 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 2 | 1 | 6 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 1 | 6 |
| Luciferase | 5 | 0 | 0 | 5 |
| glp-1 receptor, partial | 7 | 0 | 0 | 7 |
| hypoxia-inducible factor 1 alpha subunit | 3 | 0 | 0 | 3 |
| RAR-related orphan receptor gamma | 7 | 0 | 0 | 7 |
| ATAD5 protein, partial | 9 | 0 | 0 | 9 |
| Fumarate hydratase | 4 | 0 | 0 | 4 |
| TDP1 protein | 12 | 0 | 0 | 12 |
| AR protein | 15 | 0 | 0 | 15 |
| caspase 7, apoptosis-related cysteine protease | 4 | 0 | 0 | 4 |
| progesterone receptor | 9 | 0 | 0 | 9 |
| farnesoid X nuclear receptor | 5 | 0 | 0 | 5 |
| pregnane X nuclear receptor | 11 | 0 | 0 | 11 |
| estrogen nuclear receptor alpha | 17 | 0 | 0 | 17 |
| polyprotein | 4 | 0 | 0 | 4 |
| 67.9K protein | 3 | 0 | 0 | 3 |
| peroxisome proliferator activated receptor gamma | 4 | 0 | 0 | 4 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 7 | 0 | 0 | 7 |
| caspase-3 | 4 | 0 | 0 | 4 |
| IDH1 | 5 | 0 | 0 | 5 |
| aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 5 | 0 | 0 | 5 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 5 | 0 | 0 | 5 |
| nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
| Histone H2A.x | 3 | 0 | 0 | 3 |
| cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 3 | 0 | 0 | 3 |
| chromobox protein homolog 1 | 11 | 0 | 0 | 11 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 5 | 0 | 0 | 5 |
| transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform 2 | 10 | 0 | 0 | 10 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| heat shock protein beta-1 | 3 | 0 | 0 | 3 |
| mitogen-activated protein kinase 1 | 5 | 0 | 0 | 5 |
| urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
| plasminogen precursor | 1 | 0 | 0 | 1 |
| urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
| Vif | 0 | 0 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
| lamin isoform A-delta10 | 10 | 0 | 0 | 10 |
| neuropeptide S receptor isoform A | 3 | 0 | 0 | 3 |
| Voltage-dependent calcium channel gamma-2 subunit | 6 | 0 | 0 | 6 |
| Interferon beta | 8 | 0 | 0 | 8 |
| Cellular tumor antigen p53 | 7 | 0 | 0 | 7 |
| Integrin beta-3 | 2 | 1 | 1 | 4 |
| Integrin alpha-IIb | 2 | 1 | 1 | 4 |
| Methionine aminopeptidase | 0 | 1 | 0 | 1 |
| Glutamate receptor 2 | 6 | 2 | 1 | 9 |
| Inositol monophosphatase 1 | 5 | 0 | 0 | 5 |
| ATPase family AAA domain-containing protein 5 | 5 | 0 | 0 | 5 |
| Ataxin-2 | 6 | 0 | 0 | 6 |
| USP1 protein, partial | 6 | 0 | 0 | 6 |
| peroxisome proliferator-activated receptor delta | 8 | 0 | 0 | 8 |
| Cytochrome P450 2J2 | 0 | 6 | 0 | 7 |
| Nicotinate phosphoribosyltransferase | 0 | 2 | 0 | 2 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 8 | 0 | 0 | 8 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| phosphopantetheinyl transferase | 6 | 0 | 0 | 6 |
| NFKB1 protein, partial | 4 | 0 | 0 | 4 |
| GLS protein | 10 | 0 | 0 | 10 |
| thyroid stimulating hormone receptor | 9 | 0 | 0 | 9 |
| alpha-galactosidase | 2 | 0 | 0 | 2 |
| cytochrome P450 2C19 precursor | 5 | 0 | 0 | 5 |
| flap endonuclease 1 | 3 | 0 | 0 | 3 |
| DNA polymerase iota isoform a (long) | 7 | 0 | 0 | 7 |
| muscarinic acetylcholine receptor M1 | 6 | 0 | 0 | 6 |
| lethal factor (plasmid) | 4 | 0 | 0 | 4 |
| Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 7 | 0 | 0 | 7 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| Chain A, HADH2 protein | 5 | 0 | 0 | 5 |
| Chain B, HADH2 protein | 5 | 0 | 0 | 5 |
| Chain A, 2-oxoglutarate Oxygenase | 4 | 0 | 0 | 4 |
| GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
| ras protein, partial | 0 | 0 | 1 | 1 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | 7 | 0 | 0 | 7 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| EWS/FLI fusion protein | 14 | 0 | 0 | 14 |
| cytochrome P450 2D6 | 8 | 0 | 0 | 8 |
| glucocerebrosidase | 3 | 0 | 0 | 3 |
| Rac1 protein | 0 | 0 | 1 | 1 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
| DNA polymerase kappa isoform 1 | 5 | 0 | 0 | 5 |
| Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| Urotensin-2 receptor | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
| Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 5 | 1 | 6 |
| Sigma non-opioid intracellular receptor 1 | 0 | 3 | 1 | 4 |
| Chain A, Cruzipain | 3 | 0 | 0 | 3 |
| SMAD family member 2 | 3 | 0 | 0 | 3 |
| SMAD family member 3 | 3 | 0 | 0 | 3 |
| estrogen receptor 2 (ER beta) | 4 | 0 | 0 | 4 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 5 | 0 | 0 | 5 |
| caspase-3 | 1 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 0 | 0 | 2 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 5 |
| Insulin receptor | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 3 | 0 | 3 |
| Histone deacetylase 1 | 0 | 1 | 0 | 1 |
| Histone deacetylase 2 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 5 |
| Histone deacetylase 6 | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 3 | 0 | 4 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 4 | 0 | 6 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
| Microtubule-associated protein tau | 5 | 0 | 0 | 5 |
| caspase-1 isoform alpha precursor | 2 | 0 | 0 | 2 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 2 | 0 | 1 | 2 | 3 |
| Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 7 | 0 | 0 | 7 |
| Vpr | 1 | 0 | 0 | 1 |
| Bile salt export pump | 0 | 6 | 0 | 6 |
| Albumin | 0 | 0 | 3 | 3 |
| Major prion protein | 0 | 0 | 2 | 2 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 3 |
| Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 3 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 8 | 0 | 8 |
| Sodium channel protein type 9 subunit alpha | 0 | 3 | 0 | 3 |
| Frizzled-8 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
| endonuclease IV | 2 | 0 | 0 | 2 |
| Thrombopoietin | 2 | 0 | 0 | 2 |
| G | 7 | 0 | 0 | 7 |
| bromodomain adjacent to zinc finger domain 2B | 4 | 0 | 0 | 4 |
| thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
| peripheral myelin protein 22 isoform 1 | 5 | 0 | 0 | 5 |
| cytochrome P450 2C9 precursor | 5 | 0 | 0 | 5 |
| nuclear receptor ROR-gamma isoform 1 | 6 | 0 | 0 | 6 |
| cytochrome P450 3A4 isoform 1 | 5 | 0 | 0 | 5 |
| M-phase phosphoprotein 8 | 5 | 0 | 0 | 5 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 5 | 0 | 5 |
| HLA class I histocompatibility antigen, B alpha chain | 7 | 0 | 0 | 7 |
| Histamine H2 receptor | 5 | 1 | 0 | 8 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 9 | 0 | 0 | 9 |
| Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 5 | 0 | 5 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 5 | 0 | 5 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 5 | 0 | 5 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 2 | 0 | 2 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 7 | 0 | 0 | 7 |
| cytochrome P450 2C9, partial | 7 | 0 | 0 | 7 |
| nonstructural protein 1 | 4 | 0 | 0 | 4 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
| Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 9 | 0 | 9 |
| Rap guanine nucleotide exchange factor 4 | 2 | 0 | 0 | 2 |
| P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
| 5-hydroxytryptamine receptor 3E | 0 | 3 | 0 | 3 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 1 | 0 | 2 | 0 | 2 |
| cytochrome P450 2D6 isoform 1 | 5 | 0 | 0 | 5 |
| D(1A) dopamine receptor | 4 | 0 | 0 | 4 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 7 | 0 | 0 | 7 |
| DNA polymerase beta | 2 | 0 | 0 | 2 |
| atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
| transient receptor potential cation channel subfamily V member 1 | 2 | 0 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 6 | 0 | 6 |
| 5-hydroxytryptamine receptor 3B | 0 | 3 | 0 | 3 |
| Aldo-keto reductase family 1 member B1 | 0 | 6 | 0 | 6 |
| Muscarinic acetylcholine receptor M2 | 0 | 6 | 1 | 7 |
| Muscarinic acetylcholine receptor M4 | 0 | 6 | 1 | 7 |
| Muscarinic acetylcholine receptor M1 | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M3 | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M4 | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 1A | 0 | 8 | 2 | 10 |
| Muscarinic acetylcholine receptor M5 | 0 | 5 | 0 | 5 |
| Muscarinic acetylcholine receptor M5 | 0 | 7 | 0 | 7 |
| Alpha-2A adrenergic receptor | 0 | 12 | 1 | 13 |
| Calmodulin-1 | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M2 | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M1 | 0 | 7 | 1 | 8 |
| Angiotensin-converting enzyme | 0 | 3 | 0 | 3 |
| D(2) dopamine receptor | 0 | 9 | 1 | 16 |
| Alpha-1B adrenergic receptor | 0 | 10 | 2 | 12 |
| Alpha-2B adrenergic receptor | 0 | 11 | 0 | 11 |
| Beta-1 adrenergic receptor | 0 | 3 | 0 | 3 |
| Alpha-2C adrenergic receptor | 0 | 12 | 1 | 13 |
| D | 0 | 7 | 0 | 7 |
| D(3) dopamine receptor | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 1A | 0 | 7 | 0 | 7 |
| Alpha-2B adrenergic receptor | 0 | 7 | 2 | 9 |
| D(2) dopamine receptor | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M3 | 0 | 6 | 1 | 7 |
| Endothelin receptor type B | 0 | 2 | 0 | 2 |
| D(1A) dopamine receptor | 0 | 7 | 0 | 9 |
| D(4) dopamine receptor | 0 | 7 | 1 | 12 |
| D(1B) dopamine receptor | 0 | 3 | 0 | 5 |
| Adenylate cyclase type 3 | 0 | 2 | 0 | 2 |
| Alpha-2C adrenergic receptor | 0 | 7 | 2 | 9 |
| UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 7 | 2 | 9 |
| Alpha-1D adrenergic receptor | 0 | 10 | 2 | 12 |
| Sodium-dependent noradrenaline transporter | 0 | 6 | 0 | 6 |
| Sodium-dependent dopamine transporter | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 3A | 0 | 4 | 0 | 4 |
| Endothelin receptor type B | 0 | 2 | 0 | 2 |
| Histamine H2 receptor | 0 | 6 | 0 | 6 |
| Alpha-1D adrenergic receptor | 0 | 8 | 0 | 8 |
| D(1B) dopamine receptor | 0 | 4 | 0 | 4 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 2 | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 4 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 9 | 0 | 12 |
| 5-hydroxytryptamine receptor 2C | 0 | 8 | 1 | 9 |
| 5-hydroxytryptamine receptor 1B | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 1D | 0 | 5 | 0 | 5 |
| D(4) dopamine receptor | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 1F | 0 | 5 | 0 | 5 |
| Histamine H1 receptor | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 7 | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 6 | 0 | 6 |
| Alpha-1A adrenergic receptor | 0 | 7 | 1 | 8 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| Histamine H1 receptor | 0 | 8 | 2 | 13 |
| Alpha-1B adrenergic receptor | 0 | 5 | 1 | 6 |
| D(3) dopamine receptor | 0 | 8 | 1 | 13 |
| 5-hydroxytryptamine receptor 3A | 0 | 3 | 0 | 3 |
| Adenylate cyclase type 8 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 7 | 1 | 8 |
| Alpha-1A adrenergic receptor | 0 | 10 | 2 | 12 |
| 5-hydroxytryptamine receptor 3A | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 6 | 0 | 6 | 0 | 8 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| Gastrin/cholecystokinin type B receptor | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| Calmodulin | 0 | 0 | 1 | 1 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 6 | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 5 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Transporter | 0 | 3 | 0 | 3 |
| Cholecystokinin receptor type A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 3D | 0 | 3 | 0 | 3 |
| Adenylyl cyclase 7 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 3C | 0 | 3 | 0 | 3 |
| D | 0 | 3 | 0 | 3 |
| Histamine H4 receptor | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 3B | 0 | 3 | 0 | 3 |
| Transporter | 0 | 5 | 0 | 5 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | 0 | 1 | 0 | 1 |
| Chain A, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
| Chain B, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
| Chain A, Slr1257 protein | 0 | 0 | 1 | 1 |
| Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] | 0 | 1 | 0 | 1 |
| regulator of G-protein signaling 4 | 5 | 0 | 0 | 5 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
| Metabotropic glutamate receptor 8 | 0 | 2 | 0 | 2 |
| Metabotropic glutamate receptor 6 | 0 | 1 | 1 | 3 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Excitatory amino acid transporter 4 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
| Bifunctional aspartokinase/homoserine dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 2 | 2 | 4 |
| ATP-citrate synthase | 0 | 1 | 0 | 1 |
| Glutamate receptor 1 | 0 | 2 | 1 | 3 |
| Glutamate receptor 3 | 0 | 2 | 1 | 3 |
| Glutamate receptor 4 | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, kainate 1 | 0 | 2 | 1 | 3 |
| Metabotropic glutamate receptor 1 | 0 | 1 | 1 | 2 |
| Metabotropic glutamate receptor 2 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 3 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 2 |
| Metabotropic glutamate receptor 5 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 6 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 7 | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 1 | 5 |
| Glutamate receptor ionotropic, kainate 1 | 0 | 1 | 1 | 2 |
| Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 3 |
| Glutamate receptor ionotropic, kainate 2 | 0 | 2 | 1 | 3 |
| Glutamate receptor 1 | 0 | 2 | 1 | 3 |
| Glutamate receptor 2 | 0 | 2 | 1 | 3 |
| Glutamate receptor 3 | 0 | 1 | 1 | 2 |
| Glutamate receptor ionotropic, kainate 3 | 0 | 2 | 0 | 2 |
| Excitatory amino acid transporter 1 | 0 | 2 | 0 | 3 |
| Excitatory amino acid transporter 2 | 0 | 2 | 0 | 3 |
| Excitatory amino acid transporter 3 | 0 | 2 | 0 | 3 |
| Metabotropic glutamate receptor 8 | 0 | 0 | 1 | 1 |
| Glutamate receptor 4 | 0 | 2 | 1 | 3 |
| Excitatory amino acid transporter 3 | 0 | 0 | 0 | 1 |
| Glutamate racemase | 0 | 0 | 0 | 1 |
| Metabotropic glutamate receptor 8 | 0 | 1 | 1 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 3 | 1 | 5 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 3 | 1 | 5 |
| Glutamate receptor ionotropic, kainate 4 | 0 | 2 | 0 | 2 |
| Glutamate carboxypeptidase 2 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 2 | 0 | 1 | 1 | 2 |
| Glutamate receptor ionotropic, kainate 3 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 1 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 2 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 7 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 3 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 3 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 5 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 3 | 1 | 5 |
| Glutamate receptor ionotropic, kainate 5 | 0 | 2 | 0 | 2 |
| Glutamate racemase | 0 | 0 | 0 | 1 |
| Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 3 | 1 | 5 |
| Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 3 | 1 | 5 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
| Parkin | 2 | 0 | 0 | 2 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
| ATP-binding cassette sub-family C member 9 | 0 | 1 | 0 | 1 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| ATP synthase subunit beta, mitochondrial | 0 | 1 | 0 | 1 |
| ATP synthase subunit delta, mitochondrial | 0 | 1 | 0 | 1 |
| ATP synthase subunit gamma, mitochondrial | 0 | 1 | 0 | 1 |
| ATP synthase subunit epsilon, mitochondrial | 0 | 1 | 0 | 1 |
| Cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
| Cholesteryl ester transfer protein | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 1 | 0 | 1 |
| Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 8 | 0 | 1 | 0 | 1 |
| ATP-sensitive inward rectifier potassium channel 11 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 1 | 0 | 1 |
| Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
| NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
| NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
| CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
| 15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| Cocaine esterase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 2 |
| Vitamin D-binding protein | 0 | 1 | 0 | 1 |
| HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
| Integrin beta-1 | 0 | 1 | 0 | 1 |
| Integrin alpha-4 | 0 | 1 | 0 | 1 |
| Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 2 | 1 | 3 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| AP-2 complex subunit sigma | 0 | 1 | 0 | 1 |
| N-acetyltransferase Eis | 0 | 2 | 0 | 2 |
| Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
| TAR DNA-binding protein 43 | 4 | 0 | 0 | 4 |
| Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
| Calcitonin gene-related peptide type 1 receptor | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 2 | 0 | 2 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Zinc finger protein 664 | 0 | 1 | 0 | 1 |
| Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
| Protease | 0 | 2 | 0 | 2 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
| dopamine D1 receptor | 3 | 0 | 0 | 3 |
| WRN | 1 | 0 | 0 | 1 |
| integrase, partial | 0 | 1 | 0 | 1 |
| lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
| pyruvate kinase | 1 | 0 | 0 | 1 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
| snurportin-1 | 2 | 0 | 0 | 2 |
| DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
| Polyphenol oxidase 2 | 0 | 0 | 0 | 1 |
| Plasma kallikrein | 0 | 0 | 0 | 1 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| SLC16A10 protein | 0 | 0 | 0 | 1 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| Prothrombin | 0 | 1 | 0 | 1 |
| Coagulation factor X | 0 | 2 | 0 | 2 |
| Plasminogen | 0 | 1 | 0 | 1 |
| Tissue-type plasminogen activator | 0 | 1 | 0 | 1 |
| Cationic trypsin | 0 | 1 | 0 | 1 |
| Trypsin-1 | 0 | 1 | 0 | 1 |
| Trypsin-2 | 0 | 1 | 0 | 1 |
| Trypsin-3 | 0 | 1 | 0 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 3 | 0 | 0 | 3 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| ClpP | 1 | 0 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
| nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
| Toll-like receptor 4 | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 0 | 1 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| High mobility group protein B1 | 0 | 0 | 1 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 2 | 4 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Folate receptor beta | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Folate receptor alpha | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Histidine decarboxylase | 0 | 1 | 0 | 1 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 2 | 0 | 0 | 1 | 1 |
| Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
| Multidrug resistance-associated protein 1 | 0 | 0 | 0 | 1 |
| Reduced folate transporter | 0 | 2 | 0 | 2 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Pteridine reductase 1 | 0 | 1 | 0 | 1 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
| Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
| Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
| Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
| huntingtin isoform 2 | 1 | 0 | 0 | 1 |
| ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
| Endothelin-1 receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
| Type-2 angiotensin II receptor | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 5B | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3B | 0 | 2 | 0 | 2 |
| G-protein coupled receptor | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit beta-4 | 0 | 1 | 0 | 1 |
| Voltage-dependent P/Q-type calcium channel subunit alpha-1A | 0 | 1 | 0 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1G | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-3 subunit | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1H | 0 | 1 | 0 | 1 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit beta-3 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-7 subunit | 0 | 1 | 0 | 1 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit beta-1 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-1 subunit | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit beta-2 | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Voltage-dependent R-type calcium channel subunit alpha-1E | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-4 | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-3 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-8 subunit | 0 | 1 | 0 | 1 |
| Bile acid receptor | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-6 subunit | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-2 | 0 | 1 | 0 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1I | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-4 subunit | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-5 subunit | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-2 subunit | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
| Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
| Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
| Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
| Sterol 14-alpha-demethylase | 0 | 0 | 1 | 1 |
| 14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
| Cholesterol side-chain cleavage enzyme, mitochondrial | 0 | 0 | 1 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
| Cytochrome P450 144 | 0 | 0 | 1 | 1 |
| Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
| Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
| Sterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
| 14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
| 14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
| Cholesterol 24-hydroxylase | 0 | 2 | 1 | 3 |
| thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
| Aspartate aminotransferase, cytoplasmic | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |